Abree Johnson, MS, MBA

University of Maryland School of Pharmacy, United States

Disclosure information not submitted.

Presentation(s):

• 1D-03 - Recombinant Zoster Vaccine and Risk of Incident Guillain-Barré Syndrome in US Adults ≥ 65 Years of Age

  Sunday, August 24, 2025
  11:00 AM - 11:15 AM ET

• 2A-04 - Changes in Initial Treatment Types of Medication for Opioid Use Disorder Among Medicaid Beneficiaries

  Sunday, August 24, 2025
  4:15 PM - 4:30 PM ET